NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM651845 Query DataSets for GSM651845
Status Public on Feb 15, 2011
Title Cervical cancer-lymph node negative-15-48
Sample type RNA
 
Source name Early stage cervical cancer
Organism Homo sapiens
Characteristics pelvic lymph nodes: Negative
age at diagnosis: 68.9
figo stage: 2a
Treatment protocol Primary treatment consisted of type 3 radical hysterectomy and pelvic lymph node dissection. In case of poor prognostic factors, such as lymph node metastases or positive resection margins, patients were treated with adjuvant radiotherapy or chemoradiation.
Extracted molecule total RNA
Extraction protocol From the frozen biopsies, four 10 mm thick sections were cut and used for standard RNA isolation. After cutting, a 3 mm thick section was stained with hematoxylin/eosin for histological examination and only tissues with >80% tumor cells were included. RNA was isolated with TRIzol reagent (Invitrogen, Breda, the Netherlands) according to manufacturer's protocol. RNA was treated with DNAse and purified using the RNeasy mini-kit (Qiagen, Westburg, Leusden, the Netherlands). The quality and quantity of the RNA was determined by Agilent Lab-on-Chip analysis.
Label Biotin
Label protocol For labelling, 10 μg of total RNA was amplified by in vitro transcription using T7 RNA polymerase, according to standard Affymetrix protocols.
 
Hybridization protocol Labelled RNA samples were hybridized according to a randomized design to the human genome U133 plus 2.0 microarrays (Affymetrix, Santa Clara, CA). The microarrays were loaded with 200 μl of hybridization cocktail solution and then placed in Genechip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm at 45 °C for 16 h.
Scan protocol After hybridization, the arrays were washed on Genechip Fluidics Station 400 (Affymetrix) and scanned using Genechip Scanner 3000 (Affymetrix) according to the manufacturers’ procedure. Labeling of the RNA, quality control, the microarray hybridization and scanning were performed by ServiceXS (Leiden, the Netherlands ) according to Affymetrix standards.
Description Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis
Data processing Processing of CEL files was performed with Affymetrix Expression Console software. Probe set expression summary was done using the Robust Multi-array Average (RMA) algorithm. Quality of the microarray data was checked using histograms, box plots and a RNA degradation plot. Principal component analysis (PCA) was performed for controlling the quality of the hybridizations.
 
Submission date Jan 10, 2011
Last update date Feb 15, 2011
Contact name Maartje Noordhuis
E-mail(s) m.noordhuis@og.umcg.nl
Organization name University Medical Center Groningen
Department Gynecologic Oncology
Street address PObox 30.001
City Groningen
ZIP/Postal code 9700RB
Country Netherlands
 
Platform ID GPL570
Series (1)
GSE26511 Involvement of the TGF-β and β-catenin pathways in pelvic lymph node metastasis in early stage cervical cancer

Data table header descriptions
ID_REF
VALUE Gene expressions were normalized and log-transformed

Data table
ID_REF VALUE
AFFX-BioB-5_at 7.49337
AFFX-BioB-M_at 8.23975
AFFX-BioB-3_at 7.15702
AFFX-BioC-5_at 8.5616
AFFX-BioC-3_at 8.53767
AFFX-BioDn-5_at 8.92121
AFFX-BioDn-3_at 11.0264
AFFX-CreX-5_at 11.8764
AFFX-CreX-3_at 12.4299
AFFX-DapX-5_at 4.12138
AFFX-DapX-M_at 3.9985
AFFX-DapX-3_at 4.33496
AFFX-LysX-5_at 3.76027
AFFX-LysX-M_at 4.4695
AFFX-LysX-3_at 5.51262
AFFX-PheX-5_at 3.94713
AFFX-PheX-M_at 3.82225
AFFX-PheX-3_at 5.80289
AFFX-ThrX-5_at 4.44013
AFFX-ThrX-M_at 3.9434

Total number of rows: 54675

Table truncated, full table size 998 Kbytes.




Supplementary file Size Download File type/resource
GSM651845.CEL.gz 8.9 Mb (ftp)(http) CEL
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap